dc.creatorMarín, Gustavo Horacio
dc.creatorGiangreco, Lucía
dc.creatorDorati, Cristian Matías
dc.creatorMordujovich de Buschiazzo, Perla
dc.creatorBoni, Silvia
dc.creatorMantilla Ponte, Hilda
dc.creatorAlfonso Arvez, María José
dc.creatorLópez Peña, Mónica
dc.creatorAldunate González, María Francisca
dc.creatorChing Fung, Shing Mi
dc.creatorBarcelona, Laura
dc.creatorCampaña, Laura
dc.creatorVaquero Orellana, Alejandra
dc.creatorOrjuela Rodríguez, Tatiana
dc.creatorGinés Cantero, Larissa
dc.creatorVillar, Rosa A.
dc.creatorSandoval Fuentes, Nicole
dc.creatorMelero, Emiliano
dc.creatorMarin Piva, Hugo
dc.creatorSoler, Gisela
dc.creatorGabriel, Fernanda
dc.creatorPineda Velandia, Laura
dc.creatorOjeda Florentín, Cinthia
dc.creatorRisso Patron, Soledad
dc.creatorOrtiz Rivas, Mariela
dc.creatorMendoza Benítez, Carolina
dc.creatorMellado, Rosemarie
dc.creatorIvanovska, Verica
dc.creatorMuller, Arno
dc.creatorRojas, Robin
dc.creatorCastro, José Luis
dc.date2022
dc.date2023-08-23T16:59:28Z
dc.date.accessioned2024-07-24T03:41:52Z
dc.date.available2024-07-24T03:41:52Z
dc.identifierhttp://sedici.unlp.edu.ar/handle/10915/156739
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9534912
dc.descriptionBackground: Irrational antimicrobial consumption (AMC) became one of the main global health problems in recent decades. Objective: In order to understand AMC in Latin-American Region, we performed the present research in 6 countries. Methods: Antimicrobial consumption (J01, A07A, P01AB groups) was registered in Argentina, Chile, Colombia, Costa Rica, Paraguay, and Peru. Source of information, AMC type, DDD (Defined Daily Doses), DID (DDD/1000 inhabitants/day), population were variables explored. Data was analyzed using the Global Antimicrobial Resistance and Use Surveillance System (GLASS) tool. Results: Source of information included data from global, public, and private sectors. Total AMC was highly variable (range 1.91-36.26 DID). Penicillin was the most consumed group in all countries except in Paraguay, while macrolides and lincosamides were ranked second. In terms of type of AMC according to the WHO-AWaRe classification, it was found that for certain groups like “Reserve,” there are similarities among all countries. Conclusion and Relevance: This paper shows the progress that 6 Latin-American countries made toward AMC surveillance. The study provides a standardized approach for building a national surveillance system for AMC data analysis. These steps will contribute to the inclusion of Latin-America among the regions of the world that have periodic, regular, and quality data of AMC.
dc.descriptionFacultad de Ciencias Médicas
dc.formatapplication/pdf
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc/4.0/
dc.rightsCreative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
dc.subjectCiencias Médicas
dc.subjectantimicrobial
dc.subjectconsumption
dc.subjectdata source
dc.subjectinformation
dc.subjectGLASS
dc.subjectLatin America
dc.titleAntimicrobial Consumption in Latin American Countries: First Steps of a Long Road Ahead
dc.typeArticulo
dc.typeArticulo


Este ítem pertenece a la siguiente institución